Patent · US Active

Derivatives of pyridinone as inhibitors for tissue transglutaminase

US9434763B2 · kind B2 · utility

1Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 12, 2013
Grant dateSep 6, 2016
Priority date
Expiry dateJul 12, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K5/1024
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to pyridinone derivatives of general formula (I) as inhibitors of tissue transglutaminase, to methods for producing the pyridinone derivatives, to pharmaceutical compositions containing said pyridinone derivatives and to their use for the prophylaxis and treatment of diseases associated with tissue transglutaminase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.